Ear infections are common in kids, but it can be jarring when you suddenly develop one as an adult. After all, they can be really uncomfortable, and it’s probably been a minute since you’ve had one.

Many people have experienced the pain and thumping that accompany a middle ear infection, and they're especially common in children. Learn more about these common infections, their causes, symptoms ...

Ear infections are the most common reason parents take their child to a doctor. In fact, data shows that 5 out of 6 children will have at least one ear infection by their third birthday, making ...

Urinary tract infections (UTIs) are common in adults 65 and older, mainly due to age-related factors like malnutrition, poor ...

Infections happen year-round, but peak whooping cough season lasts from late summer through fall. Pertussis is a cyclical disease, meaning it might spread widely through a community and then disappear ...

Every time Jason publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Exposure to viral infections, like cytomegalovirus, herpes simplex viruses 1 and 2, and the protozoa Toxoplasma gondii, may accelerate cognitive decline in otherwise healthy older adults, according to ...

An ear infection can present as a dull, persistent ache, and is sometimes accompanied by pressure, discharge, itching, fever or muffled hearing. In more severe cases, the pain can be sudden, sharp and ...

EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicated intra-abdominal infections, including those caused by ...

The CDC offers a free, downloadable guideline for treatment of upper respiratory tract infections. The guideline, titled Adult Appropriate Antibiotic Use Summary, can be used in small group or ...

MORRISTOWN, N.J.--(BUSINESS WIRE)--Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today announced that the U.S.